New York Life Investment Management’s ChemoCentryx, Inc. CCXI Stock Holding History

New York Life Investment Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-243,522	Closed	-$12.6M	–	1222
2022 Q3	$12.6M	Buy	+243,522	New	+$10.1M	0.15%	145

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

New York Life Investment Management's CCXI Position: Q4 2022 in Review

New York Life Investment Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 243,522 shares — an estimated $12.6M sold.

New York Life Investment Management first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $12.6M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

New York Life Investment Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
New York Life Investment Management sold 243,522 ChemoCentryx, Inc. shares in Q4 2022, an estimated $12.6M.
New York Life Investment Management first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
New York Life Investment Management's ChemoCentryx, Inc. position peaked at $12.6M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on New York Life Investment Management's 13F filing for Q4 2022, filed 10 Feb 2023.